Femasys (FEMY) Preferred Stock Liabilities (2020 - 2021)

Femasys (FEMY) posted Preferred Stock Liabilities of $55.3 million for Q1 2021, little changed on a QoQ basis from $55.3 million in Q4 2020.

Femasys (FEMY) Preferred Stock Liabilities (2020 - 2021) Analysis & Trends

Femasys' Preferred Stock Liabilities history runs 2 years deep, the most recent figure standing at $55.3 million for Q1 2021.

  • Quarterly Preferred Stock Liabilities changed N/A year-over-year to $55.3 million in Q1 2021, while the trailing twelve-month figure through Mar 2021 was $55.3 million (changed N/A YoY) and the FY2020 annual result came in at $55.3 million, changed N/A from the prior year.
  • Preferred Stock Liabilities was $55.3 million for Q1 2021 at Femasys, roughly flat from $55.3 million in the prior quarter.
  • Across five years, Preferred Stock Liabilities topped out at $55.3 million in Q2 2020 and bottomed at $55.3 million in Q2 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Alcon 32,734,969.19 Bn 32,734,967.53 Bn 1.53 Bn -
2 Intuitive Surgical 117.50 Bn 112.41 Bn 1.96 Bn -
3 Becton Dickinson 42.93 Bn 42.11 Bn 2.15 Bn -
4 Medline 30.82 Bn 36.66 Bn 1.84 Bn -
5 Resmed 27.90 Bn 26.23 Bn 890.98 Mn -
6 West Pharmaceutical Services 26.76 Bn 26.23 Bn 329.20 Mn -
7 Cooper Companies 15.30 Bn 15.16 Bn 735.40 Mn -
8 Solventum 13.46 Bn 12.90 Bn 1.10 Bn -
9 Align Technology 12.02 Bn 10.96 Bn 736.59 Mn -
10 Femasys 17.46 Mn 12.07 Mn - -

Historic Data

Download Data
DateValue
Mar 31, 2021 55.34 Mn
Dec 31, 2020 55.34 Mn
Sep 30, 2020 55.34 Mn
Jun 30, 2020 55.34 Mn